ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D

TUESDAY, June 7, 2022 (HealthDay News) -- For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level, according to a study published online

Related Keywords

United States ,American ,Silvaa Arslanian ,Eli Lilly ,University Of Pittsburgh School Medicine ,American Diabetes Association ,Healthday News ,New England Journal ,Pittsburgh School ,Physicians Briefing ,